Email Us Here

BioScience Laboratories Announces Clinical Studies Capabilities for H1N1 Influenza

BioScience Laboratories has received approval from the Gallatin Institutional Review Board to test antiviral efficacy against H1N1 influenza A/Brisbane/59/2007, IVR-148 using healthy human subjects.